RecallRadar

FDA Drug recall D-1348-2014

Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharm…

On 2014-05-28 the FDA classified a Class II recall of Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharm… by Forest Pharmaceuticals, citing failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf li….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1348-2014
ClassificationClass II
Statusterminated
Initiated2014-05-12
Published2014-05-28
Last updated2026-09-13 11:51 UTC
CompanyForest Pharmaceuticals
DistributionUS

Product

Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharmaceutica NV, Belgium, Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, NDC 0456-1420-30

Reason

Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.

Identifiers

ndc0456-1402-30
ndc0456-1402-90
ndc0456-1402-01
ndc0456-1402-63
ndc0456-1405-30
ndc0456-1405-90
ndc0456-1405-01
ndc0456-1405-63
ndc0456-1410-30
ndc0456-1410-90
ndc0456-1410-01
ndc0456-1410-63
ndc0456-1420-30
ndc0456-1420-90
ndc0456-1420-01
ndc0456-1420-63
code_infoLot: A287945, Exp: 08/2015

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1348-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.